OBJECTIVE: Skeletal muscle blood flow during exercise is impaired in obesity. We tested the hypothesis that the attenuated vasodilation in skeletal muscle arterioles of obese Zucker rats (OZR) is due to altered K(ATP) channel-mediated vasodilation. MATERIALS AND METHODS: K(ATP) channel function was determined in isolated skeletal muscle arterioles in response to the K(ATP) opener cromakalim (0.1-10 microM) during normal myogenic tone and alpha-adrenergic-mediated tone (0.1 microM phenylephrine). The spinotrapezius muscle was prepared and the vasodilatory responses to muscle stimulation or iloprost (0.028-2.8 microM) were observed before and after the application of the K(ATP) inhibitor, glibenclamide (10 microM). Channel subunit expression was determined by using western blot analyses. RESULTS: Cromakalim concentration-response curves were shifted in OZR as compared to lean controls. OZR exhibited impaired functional and iloprost-induced vasodilation as compared to the lean controls. Glibenclamide inhibited the functional and iloprost-induced dilation in the lean rats with no effects in the obese a nimals. Channel subunit expression was similar in femoral arteries. CONCLUSION: The impaired functional vasodilation in the OZR is associated with altered K(ATP) channel sensitivity.
OBJECTIVE: Skeletal muscle blood flow during exercise is impaired in obesity. We tested the hypothesis that the attenuated vasodilation in skeletal muscle arterioles of obese Zucker rats (OZR) is due to altered K(ATP) channel-mediated vasodilation. MATERIALS AND METHODS: K(ATP) channel function was determined in isolated skeletal muscle arterioles in response to the K(ATP) opener cromakalim (0.1-10 microM) during normal myogenic tone and alpha-adrenergic-mediated tone (0.1 microM phenylephrine). The spinotrapezius muscle was prepared and the vasodilatory responses to muscle stimulation or iloprost (0.028-2.8 microM) were observed before and after the application of the K(ATP) inhibitor, glibenclamide (10 microM). Channel subunit expression was determined by using western blot analyses. RESULTS:Cromakalim concentration-response curves were shifted in OZR as compared to lean controls. OZR exhibited impaired functional and iloprost-induced vasodilation as compared to the lean controls. Glibenclamide inhibited the functional and iloprost-induced dilation in the lean rats with no effects in the obese a nimals. Channel subunit expression was similar in femoral arteries. CONCLUSION: The impaired functional vasodilation in the OZR is associated with altered K(ATP) channel sensitivity.
Authors: C E Negrão; I C Trombetta; L T Batalha; M M Ribeiro; M U Rondon; T Tinucci; C L Forjaz; A C Barretto; A Halpern; S M Villares Journal: Am J Physiol Heart Circ Physiol Date: 2001-08 Impact factor: 4.733
Authors: M E Lott; C S Hogeman; L Vickery; A R Kunselman; L I Sinoway; D A MacLean Journal: Am J Physiol Heart Circ Physiol Date: 2001-10 Impact factor: 4.733
Authors: Léna Borbouse; Gregory M Dick; Gregory A Payne; Zachary C Berwick; Zachary P Neeb; Mouhamad Alloosh; Ian N Bratz; Michael Sturek; Johnathan D Tune Journal: Am J Physiol Heart Circ Physiol Date: 2010-01-29 Impact factor: 4.733
Authors: Adam Institoris; Laura Lenti; Ferenc Domoki; Edina Wappler; Tamás Gáspár; Prasad V Katakam; Ferenc Bari; David W Busija Journal: Microcirculation Date: 2012-11 Impact factor: 2.628
Authors: John D Imig; Katie A Walsh; Md Abdul Hye Khan; Tasuku Nagasawa; Mary Cherian-Shaw; Sean M Shaw; Bruce D Hammock Journal: Exp Biol Med (Maywood) Date: 2012-12
Authors: Jacqueline K Limberg; John W Harrell; Rebecca E Johansson; Marlowe W Eldridge; Lester T Proctor; Joshua J Sebranek; William G Schrage Journal: Am J Physiol Heart Circ Physiol Date: 2013-08-09 Impact factor: 4.733
Authors: Benjamin L Hodnett; Jennifer A Dearman; Cory B Carter; Robert L Hester Journal: Am J Physiol Regul Integr Comp Physiol Date: 2008-12-31 Impact factor: 3.619